Valuation: Elekta AB

Market Cap 20.52B 2.14B 1.86B 1.74B 1.59B 2.99B 205B 3.04B 8.01B 102B 8.05B 7.88B 342B P/E 2027 *
14.3x
P/E 2028 * 12.8x
Enterprise Value 23.98B 2.51B 2.17B 2.04B 1.86B 3.49B 239B 3.55B 9.36B 120B 9.41B 9.21B 399B EV / Sales 2027 *
1.38x
EV / Sales 2028 * 1.3x
Free-Float
-
Yield 2027 *
4.67%
Yield 2028 * 5.14%
1 day+4.64%
1 week+13.90%
Current month+16.06%
1 month+11.83%
3 months-3.07%
6 months-4.72%
Current year-4.07%
1 week 5.27
Extreme 5.27
5.86
1 month 4.63
Extreme 4.63
5.86
Current year 4.63
Extreme 4.63
6.93
1 year 4.35
Extreme 4.35
6.93
3 years 4.35
Extreme 4.35
8.62
5 years 4.35
Extreme 4.35
14.92
10 years 4.35
Extreme 4.35
15.56
Manager TitleAgeSince
Chief Executive Officer - 2025-08-31
Director of Finance/CFO - 2026-02-28
Investor Relations Contact - 2023-11-30
Director TitleAgeSince
Director/Board Member 69 2010-06-29
Director/Board Member 70 2011-09-14
Chairman 74 2013-09-02
Change 5-day change 1-year change 3-year change Capi.($)
+4.64%+13.90% - - 2.09B
-1.18%+3.13%+24.82%+9.58% 223B
-0.92%+2.12%-0.89%-20.17% 145B
0.00%+6.95%-16.09%+31.78% 142B
+0.53%+8.27%-49.64%+1.29% 74.52B
-0.53%+4.04%+20.32%+16.56% 53.63B
+0.03%-0.51%-15.63%-17.27% 50.14B
+0.71%+5.80%+27.25%+17.68% 41.87B
-0.63%+3.38%+44.83%+41.78% 40.89B
+2.09%+5.05%-0.83%+3.07% 32.65B
Average +0.67%+4.23%+3.79%+9.37% 89.23B
Weighted average by Cap. -0.19%+4.56%+3.33%+7.96%

Financials

2027 *2028 *
Net sales 17.34B 1.81B 1.57B 1.47B 1.34B 2.53B 173B 2.57B 6.77B 86.57B 6.8B 6.66B 289B 18.08B 1.89B 1.64B 1.54B 1.4B 2.63B 180B 2.68B 7.06B 90.29B 7.1B 6.94B 301B
Net income 1.43B 150M 130M 122M 111M 209M 14.29B 212M 559M 7.15B 562M 550M 23.87B 1.61B 169M 146M 137M 125M 235M 16.08B 239M 629M 8.05B 633M 619M 26.85B
Net Debt 3.47B 362M 314M 294M 268M 505M 34.57B 513M 1.35B 17.3B 1.36B 1.33B 57.72B 2.99B 312M 271M 254M 231M 435M 29.79B 442M 1.17B 14.91B 1.17B 1.15B 49.75B
Logo Elekta AB
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
3,704
Date Price Change Volume
26-08-12 US$5.415 -0.82% 2,531
26-08-11 US$5.460 +0.91% 405
26-08-10 US$5.411 +2.48% 911
26-08-07 US$5.280 +3.13% 5,639
26-08-06 US$5.120 -0.49% 1,376
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
53.70SEK
Average target price
59.96SEK
Spread / Average Target
+11.67%

Quarterly revenue - Rate of surprise